What are you searching for?

Sign in
OEM News

Medtech Marks First ROSA Surgery System Sale in U.S.

Ohio hospital buys robotic system two months after FDA clearance.

By: Medtech

Medtech, a company that designs, develops and markets surgical assistance robots, has announced the first sale of its ROSA Spine robotic surgery system in the United States to Miami Valley Hospital.

Based in Dayton, Ohio, Miami Valley Hospital is a 970-bed medical facility and recipient of the Healthgrades America’s 100 Best Hospitals’ Award in 2016. The institution also has received the Healthgrades Distinguished Hospital Award – Clinical Excellence for three consecutive years from 2014 to 2016.

“Our hospital previously purchased two ROSA Brain systems in 2015 for our Neuroscience Institute and for training in our Brethen Center for Surgical Advancement in Robotics and Minimally Invasive Surgery,” said Mark Shaker, president/CEO of Miami Valley Hospital. “We are thrilled to be the first facility in the U.S. to now have ROSA Spine, and we are confident that Medtech’s robotic technology will expand our minimally invasive spinal surgery options for the region.”                                                                                            

ROSA Spine was granted U.S. Food and Drug Administration (FDA) clearance in January, and received the CE Mark in 2014. Medtech’s ROSA Brain received FDA approval in 2012 and is currently in use in 29 U.S. facilities.

“We are proud to officially have ROSA Spine in the U.S.,” said Bertin Nahum, CEO/founder of Medtech. “This technology allows surgeons to perform minimally invasive surgical procedures on the spine and increases the safety and reliability of these operations. The U.S. market is the world’s leading market for spine surgery, and this is a first step in bringing the benefits of ROSA Spine to an even greater number of patients.”

The ROSA robotic device was designed to increase the safety and reliability of various neurological procedures without compromising established surgical protocols. ROSA is an integrated multi-application console that acts as a reliable and accurate surgical assistant.

Comparable to a “GPS” for the brain, the robot can be used for any type of cranial procedure requiring surgical planning with preoperative data, patient registration and precise positioning and handling of instruments.

To date, ROSA is the only robotic assistant approved for neurosurgical procedures in clinical use in Europe, the United States and Canada, with the following specifications: 

A robotic arm with six degrees of freedom
ROSA has a robotic arm whose architecture replicates the movements of a human arm with six degrees of freedom. This provides very high dexterity in achieving complex surgical procedures as well as allowing complete freedom in the choice of trajectories.

Advanced haptic capability
ROSA has an advanced haptic capability that gives the neurosurgeon the ability to easily guide the instruments by hand within the limits and restrictions established during the planning stage. The surgeon is able to easily interact with the robot without changing any of his surgical techniques thus reaping the full benefits of robotic movement.

A non-invasive and touch free registration system
ROSA is equipped with a patented registration system that uniquely combines precise robotic movement with non-invasive laser measurement for patient registration. This method allows the intervention to be performed without the use of invasive markers or a frame.

ROSA’s inherent flexibility empowers the surgeon in a broad range of indications, including: biopsies, implantations of electrodes for functional procedures (stimulation of the cerebral cortex, deep brain stimulation), open skull surgical procedures using navigation, ventricular and transnasal endoscopy as well as other keyhole procedures.

Medtech is based in Montpellier, France.

 

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters